Price T Rowe Associates Inc Athenex, Inc. Transaction History

Price T Rowe Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $58,848 - $127,216	-43,271 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $2,283 - $3,721	769 Added 1.81%	43,271 $130,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $157,682 - $218,035	42,502 New	42,502 $196,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.